Insulin-like growth factor-1 (IGF-1), insulin-like growth factor binding protein-3 (IGFBP-3), leptin, the HOMA (hemostasis model assessment) score, fasting glucose, and calcium-125 can be used to differentiate between ovarian tumors and benign ovarian lesions. This evidence concerns the gene IGF1 and ovarian neoplasm.